Page 3 - Latest Updates on Diabetes
Germany's Boehringer, Indian pharma in legal battle over diabetes drug
The German drug maker has obtained interim injunctions against MSN Labs and Dr Reddy's Lab
 "Germany's Boehringer, Indian pharma in legal battle over diabetes drug")
NPPA fixes price caps for 12 anti-diabetic medicines
These include glimepiride tablet of strength 1 mg, with ceiling price at Rs 3.6 per tablet, while that for 2 mg is Rs 5.72 per tablet
 "NPPA fixes price caps for 12 anti-diabetic medicines")
Study finds why people with diabetes develop severe Covid-19
A recent study by a team of international clinical researchers reveals the mechanism behind cytokine storm during coronavirus infection.
 "Study finds why people with diabetes develop severe Covid-19")
Startup Sugar.fit, which aims to reverse diabetes, to raise $10 million
Health and fitness firm Cure.fit and two others to invest the funds in a deal likely to by September
 "Startup Sugar.fit, which aims to reverse diabetes, to raise $10 million")
Wockhardt's growth tonic: Covid vaccines add a third prong to biz strategy
In India, Wockhardt aims to make 2 billion doses of Covid-19 vaccines within the next one or two years but has not disclosed the identity of the tie-ups
 "Wockhardt's growth tonic: Covid vaccines add a third prong to biz strategy")
Ethnic diversity helps identify more diabetes-related genomic regions
By including multi-ethnic participants, a large-scale genetic study by the University of Exeter has identified more regions of the genome linked to type-2 diabetes-related traits
 "Ethnic diversity helps identify more diabetes-related genomic regions")
Two pandemics clash as doctors find that coronavirus spurs diabetes
When Ziyad Al-Aly's research team told him how often diabetes appeared to strike Covid-19 survivors, he thought the data must be wrong, so he asked his five colleagues to crunch the numbers again.
 "Two pandemics clash as doctors find that coronavirus spurs diabetes")
Big Tech uses AI to arrest blindness among India's burgeoning diabetics
Diabetic retinopathy is a leading cause of blindness and vision loss in adults and tech giants such as Intel and Google are building AI-based innovations to address such problems
 "Big Tech uses AI to arrest blindness among India's burgeoning diabetics")
Covid vaccination voluntary, those already infected can also get the jab
A detailed FAQ released by health ministry has also addressed issues on suitability in co-morbid cases, delivery procedure among other things
 "Covid vaccination voluntary, those already infected can also get the jab")
AstraZeneca aims to impact 10 mn diabetics by 2023, starts awareness drive
India will have 115 mn diabetics by 2030. Forty-four per cent of patients hospitalised for heart failure have type-2 diabetes
 "AstraZeneca aims to impact 10 mn diabetics by 2023, starts awareness drive")
Diabetic eye disease associated with five-fold risk of severe coronavirus
People with diabetes and eye disease have a five-fold increased risk of requiring intubation when hospitalised with Covid-19, suggest the findings of a new study
Ahead of World Diabetes Day, experts call for action to address epidemic
Ahead of World Diabetes Day, a new report has called for action to close the gap in diabetes prevention and care
 "Ahead of World Diabetes Day, experts call for action to address epidemic")
Sun Pharma arm recalls one lot of diabetes drug Riomet ER oral in US
Sun Pharma has said it is voluntarily recalling one lot of Riomet ER oral suspension in the US market, due to the presence of a probable human carcinogen above the acceptable daily intake limit.
 "Sun Pharma arm recalls one lot of diabetes drug Riomet ER oral in US")
Lupin recalls diabetes treatment drug Metformin Hydrochloride in US
Drug major Lupin Ltd on Wednesday said it is voluntarily recalling its diabetes treatment drug Metformin Hydrochloride extended-release tablets in the US market
 "Lupin recalls diabetes treatment drug Metformin Hydrochloride in US")
Cipla, Boehringer Ingelheim to co-sell 3 oral anti-diabetic drugs in India
Pharma major Cipla and drug firm Boehringer Ingelheim India on Monday announced partnership to co-market three new oral anti-diabetic drugs in the country.
 "Cipla, Boehringer Ingelheim to co-sell 3 oral anti-diabetic drugs in India")
Covid-19 and diabetes: Different risks for people with type 1 and type 2
It is still unclear whether people with diabetes are more likely to catch the virus
Shramik trains: Rlys appeal to people with comorbidities to avoid travel
At least nine passengers were reported dead on May 27 over a span of 48 hours on board the migrant trains, with the railways stating that all of them had health conditions.
 "Shramik trains: Rlys appeal to people with comorbidities to avoid travel")
Why nutrition labels that skip ingredients like sugar make business sense
Veer Arjun Singh on why shorter, sharper nutrition labels - the kind that skip a few ingredients such as sugar by many other names - are starting to make business sense
 "Why nutrition labels that skip ingredients like sugar make business sense")
Yoga to acupuncture: Alternative therapies to prevent diabetic neuropathy
The best defense against progressive damage from diabetic neuropathy is to manage the disease itself
 "Yoga to acupuncture: Alternative therapies to prevent diabetic neuropathy")
Coronavirus scare: India may soon run short of antibiotics, diabetes drugs
Pharmaceutical firms seek nod to produce raw material locally
 "Coronavirus scare: India may soon run short of antibiotics, diabetes drugs")
